Escolar Documentos
Profissional Documentos
Cultura Documentos
February 3, 2012
Ashok Leyland
Performance Highlights
Y/E March (` cr) Net sales EBITDA EBITDA margin (%) Reported PAT
Source: Company, Angel Research
BUY
CMP Target Price
3QFY11 2,227 166 7.5 43 % chg (yoy) 29.3 26.7 (15) 54.3 Angel est. 2,742 277 10.1 108 % diff 5.0 (24.0) (279) (38.2)
`26 `32
12 Months
Investment Period
Stock Info Sector Market Cap (` cr) Beta 52 Week High / Low Avg. Daily Volume Face Value (`) BSE Sensex Nifty Reuters Code Bloomberg Code
Ashok Leylands (AL) 3QFY2012 results were significantly below our (as well as consensus) estimates at the EBITDA and net profit level led by steep increase in other expenditure and higher employee costs. Further increasing contribution from the recently launched Dost vehicles too impacted net average realization and hence profitability. We revise upwards our volume and revenue estimates for FY2012/13 as we factor in the sales of Dost into our volume estimates (5,900/33,000 units of Dost in FY2012/13) and expect overall demand scenario to improve with likely easing of interest rates from 1QFY2013. We lower our EBITDA margin estimates due to inclusion of Dost volumes which is a lower margin product. Consequently our EPS estimates are revised to `2.2/`2.7 for FY2012/13. As AL is currently trading at attractive valuations we maintain our Buy rating on the stock. Lower-than-expected performance led by steep decline in EBITDA margin: AL reported robust 29.3% yoy (down 6.9% qoq) growth in net sales to `2,880cr aided by a strong 25.9% yoy (down 1.7% qoq) growth in total volumes which benefitted from the sales of recently launched LCV Dost. Average net realization however grew by a moderate 2.7% yoy (down 5.3% qoq) on account of higher discounts and change in product mix led by introduction of lower priced Dost. EBITDA margin contracted sharply by 340bp qoq due to a substantial surge in other expenditure (annual maintenance charge of `20cr, forex loss of `15cr and increase in marketing spends mainly on Dost at `7cr) and employee costs (`16cr towards bonus payouts and `8cr due to increase in manpower at Pantnagar). Hence net profit declined 56.6% qoq to `67cr; significantly below our estimates. Outlook and valuation: At `26, AL is trading at attractive valuations of 9.7x its FY2013E earnings. We maintain our Buy rating on the stock with a target price of `32, valuing the stock at 12x its FY2013E earnings. Key financials
Y/E March (` cr) Net sales % chg Net profit % chg EBITDA (%) EPS (`) P/E (x) P/BV (x) RoE (%) RoCE (%) EV/Sales (x) EV/EBITDA (x)
Source: Company, Angel Research
Shareholding Pattern (%) Promoters MF / Banks / Indian Fls FII / NRIs / OCBs Indian Public / Others 38.6 20.6 30.0 10.8
3m 0.7 (2.4)
1yr (4.6)
3yr 92.4
(3.2) 278.2
FY2010 7,407 21.5 384 101.9 10.3 1.6 18.3 3.0 10.7 9.2 1.1 11.1
FY2011 11,366 53.4 630 64.2 10.7 2.4 11.2 2.6 16.5 14.2 0.7 6.8
FY2012E 13,146 15.7 586 (7.0) 9.8 2.2 12.0 2.3 14.2 12.6 0.6 6.5
FY2013E 16,030 21.9 725 23.8 9.5 2.7 9.7 2.0 15.9 14.0 0.5 5.3
Yaresh Kothari
022-3935 7800 Ext: 6844 yareshb.kothari@angelbroking.com
3QFY12 2,880 1,972 68.5 272 9.5 156 5.4 268 9.3 2,669 210 7.3 55 87 3 72 72 2.5 5 7.0 67 2.3 266 0.3
3QFY11 2,227 1,568 70.4 244 11.0 61 2.7 188 8.4 2,061 166 7.5 47 65 2 56 56 2.5 12 21.9 43 1.9 266 0.2
yoy chg (%) 29.3 25.7 11.6 156.9 42.8 29.5 26.7 15.9 33.9 93.2 29.6 29.6 (58.4) 54.3
2QFY12 3,095 2,183 70.6 252 8.1 92 3.0 236 7.6 2,763 331 10.7 63 86 10 193 193 6.2 39 20.1 154 5.0 266
qoq chg (%) (6.9) (9.7) 8.3 69.2 13.6 (3.4) (36.5) (12.3) 0.8 (68.7) (62.7) (62.7) (86.9) (56.6)
9MFY12 8,470 5,879 69.4 774 9.1 324 3.8 717 8.5 7,693 777 9.2 171 257 18 366 (9) 376 4.4 68 18.2 307 3.6 266
9MFY11 7,289 5,152 70.7 658 9.0 209 2.9 563 7.7 6,581 708 9.7 119 190 11 410 410 5.6 77 18.8 333 4.6 266 1.3
chg (%) 16.2 14.1 17.6 55.1 27.4 16.9 9.7 44.3 35.2 57.6 (10.7) (8.4) (11.3) (7.8)
54.3
0.6
(56.6)
1.2
(7.8)
Better-than-expected top-line growth driven by strong volume growth: AL reported better-than-expected 29.3% yoy (down 6.9% qoq) growth in net sales to `2,880cr aided by a strong 25.9% yoy (down 1.7% qoq) growth in total volumes and 2.7% yoy (down 5.3% qoq) increase in net average realization. Volume performance benefitted from the sales of recently launched LCV Dost, which posted sales of 2,490 units during the quarter. Average net realization however grew by a moderate 2.7% yoy (down 5.3% qoq) to `1,240,490 mainly on account of higher discounts and change in product mix with the introduction of lower priced Dost.
February 3, 2012
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
M&HCV passenger
M&HCV goods
Total M&HCV
23.7
3QFY12
21.0 21.1 17.8
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
EBITDA margin falls sharply to 7.3%: For 3QFY2012, ALs EBITDA margin witnessed a steep decline of 340bp qoq to 7.3%; significantly below our estimates of 10.1%. While raw-material cost to sales ratio was more or less stable during the quarter, higher employee expense and other expenditure led by number of one-off items impacted the EBITDA margin. AL reported number of one-off items during 3QFY2012, majority of which were relating to the full year but were booked during the quarter. This included 1) one-time bonus payout of `16cr towards staff costs, 2) `15cr towards annual maintenance contracts as provisions fell short of actual expense, 3) marketing spends to the tune of `7cr related mostly to the launch of Dost and 4) MTM loss of `15cr on unhedged forex contracts. As a result, the companys operating profit declined 36.5% sequentially and came in 24% below our estimates at `210cr.
February 3, 2012
3QFY12
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY10
4QFY10
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
Net profit significantly lower than expected on poor operating performance: Net profit at `67cr (down 56.6% qoq) came in significantly below our estimates on account of poor performance at the operating level. However lower tax rate at 7% led by higher R&D spends and MAT credit restricted further deterioration in profitability.
February 3, 2012
3QFY12
February 3, 2012
Investment arguments
Volume growth to benefit from easing of interest rates and recently launched Dost: MHCV demand has witnessed a slowdown in recent times due to high interest rates and slowdown in industrial activity; however, we believe MHCV demand is near its trough. With interest rates expected to cool down from CY2012, we expect pick-up in industrial activity, leading to a rebound in MHCV sales. Further, recently introduced LCV - Dost (through JV with Nissan) have been received well by the markets and AL expects to ramp-up the production in FY2013E. As such we expect AL to register a strong ~18.8% volume CAGR over FY2011-13E. EBITDA margin pressures to persist due to change in product-mix: While the raw-material prices have stabilized and AL continues to benefit from the ramp-up in production at Pantnagar facility (profitability estimated to be ~25% higher due to cost savings of ~`35,000/vehicle); the product-mix is set to change due to increasing proportion of lower margin LCV Dost (contribution to total volumes to increase from 5.9% in FY2012 to 24.9% in FY2013). AL has indicated that it earns marketing/distribution fees of `15,000-`18,000/vehicle on Dost sales and expects margins to be impacted by 50-100bp going ahead.
At `26, AL is trading at attractive valuations of 9.7x its FY2013E earnings. We maintain our Buy rating on the stock with a target price of `32, valuing the stock at 12x its FY2013E earnings.
February 3, 2012
Dec-04
Aug-07
Apr-03
Feb-04
Apr-10
Nov-05
May-09
Feb-11
Oct-06
Jan-12
Jul-08
Jul-06
Jul-07
Jul-08
Jul-09
Jul-10
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jul-11 Jul-11
May-08
Dec-03
Dec-06
Feb-09
Sep-04
Jun-05
Aug-07
Mar-06
Aug-10
Apr-03
Nov-09
Apr-11
Jan-12
Aug-05
May-08
Dec-06
Feb-11
Jul-06
Sep-09
Jan-06
Jun-07
Aug-05
Nov-07
February 3, 2012
Mar-10
Aug-10
Oct-08
Apr-09
Jan-12
Jan-12
February 3, 2012
February 3, 2012
Balance Sheet
Y/E March (` cr) SOURCES OF FUNDS Equity Share Capital Reserves & Surplus Shareholders Funds Total Loans Deferred Tax Liability Total Liabilities APPLICATION OF FUNDS Gross Block Less: Acc. Depreciation Net Block Capital Work-in-Progress Goodwill Investments Current Assets Cash Loans & Advances Other Current liabilities Net Current Assets Mis. Exp. not written off Total Assets 2,942 1,417 1,526 529 610 2,875 451 824 1,600 2,272 603 22 3,290 4,939 1,540 3,399 998 264 3,166 88 790 2,288 2,141 1,025 10 5,695 6,019 1,769 4,250 561 326 4,152 519 973 2,660 2,961 1,191 5 6,334 6,692 2,058 4,634 358 1,230 4,367 180 794 3,394 3,528 839 4 7,065 7,263 2,403 4,860 363 1,337 5,156 459 920 3,777 3,853 1,303 4 7,867 7,634 2,769 4,864 382 1,489 6,132 729 1,042 4,362 4,362 1,770 4 8,509 133 2,016 2,149 888 254 3,290 133 3,341 3,474 1,958 263 5,695 133 3,536 3,669 2,280 385 6,334 133 3,830 3,963 2,658 444 7,065 266 4,049 4,315 3,108 444 7,867 266 4,541 4,807 3,258 444 8,509 FY08 FY09 FY10 FY11 FY12E FY13E
February 3, 2012
10
(614) (2,466)
(919) (2,028)
February 3, 2012
11
Key Ratios
Y/E March Valuation Ratio (x)
P/E (on FDEPS) P/CEPS P/BV Dividend yield (%) EV/Sales EV/EBITDA EV / Total Assets Per Share Data (`) EPS (Basic) EPS (fully diluted) Cash EPS DPS Book Value Dupont Analysis EBIT margin Tax retention ratio Asset turnover (x) ROIC (Post-tax) Cost of Debt (Post Tax) Leverage (x) Operating ROE Returns (%) ROCE (Pre-tax) Angel ROIC (Pre-tax) ROE Turnover ratios (x) Asset Turnover (Gross Block) Inventory / Sales (days) Receivables (days) Payables (days) Working capital cycle (ex-cash) (days) Solvency ratios (x) Net debt to equity Net debt to EBITDA Interest Coverage (EBIT / Interest) (0.1) (0.2) 8.3 0.5 3.5 1.7 0.4 1.9 5.5 0.3 1.0 5.0 0.3 1.0 4.0 0.2 0.7 4.7 2.9 53 21 82 15 1.5 76 40 114 33 1.4 73 49 110 40 1.8 62 35 90 21 1.9 65 35 90 21 2.2 64 35 90 21 20.9 22.4 22.3 6.2 6.5 6.4 9.2 12.4 10.7 14.2 17.0 16.5 12.6 15.5 14.2 14.0 17.8 15.9 7.9 0.7 3.1 18.0 7.3 0.0 18.0 4.6 0.9 1.7 7.1 10.2 0.3 6.3 7.5 0.8 1.7 9.7 3.7 0.4 12.2 8.4 0.8 2.3 14.9 6.0 0.4 18.0 7.2 0.8 2.3 12.9 6.5 0.3 14.9 7.2 0.8 2.5 14.3 6.0 0.3 16.4 1.7 1.7 2.4 0.8 8.0 0.7 0.7 1.4 0.5 7.9 1.4 1.4 2.2 0.8 8.8 2.4 2.4 3.4 1.0 10.0 2.2 2.2 3.5 0.8 11.3 2.7 2.7 4.1 0.8 13.2 15.6 10.9 3.3 2.8 0.7 8.5 2.1 39.3 19.1 3.3 1.9 1.3 18.9 1.5 18.3 12.0 3.0 2.8 1.1 11.1 1.3 11.2 7.8 2.6 3.8 0.7 6.8 1.2 12.0 7.5 2.3 2.8 0.6 6.5 1.1 9.7 6.4 2.0 0.3 0.5 5.3 0.9 FY08 FY09 FY10 FY11 FY12E FY13E
February 3, 2012
12
E-mail: research@angelbroking.com
Website: www.angelbroking.com
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may have investment positions in the stocks recommended in this report.
Disclosure of Interest Statement 1. Analyst ownership of the stock 2. Angel and its Group companies ownership of the stock 3. Angel and its Group companies' Directors ownership of the stock 4. Broking relationship with company covered
Ashok Leyland No No No No
Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors.
Ratings (Returns):
February 3, 2012
13